Saudi Arabia Allergy Immunotherapy Market Size & Outlook, 2027

Revenue, 2019 (US$M)

$1.6

Forecast, 2027 (US$M)

$2.4

CAGR, 2020 - 2027

5.2%

Report Coverage

Saudi Arabia

Saudi Arabia allergy immunotherapy market, 2016-2027 (US$M)

Related Markets

Global Allergy Immunotherapy Industry

North America Allergy Immunotherapy Market Outlook

U.S. Allergy Immunotherapy Market Outlook

Canada Allergy Immunotherapy Market Outlook

Europe Allergy Immunotherapy Market Outlook

Germany Allergy Immunotherapy Market Outlook

France Allergy Immunotherapy Market Outlook

Asia Pacific Allergy Immunotherapy Market Outlook

Japan Allergy Immunotherapy Market Outlook

China Allergy Immunotherapy Market Outlook

Latin America Allergy Immunotherapy Market Outlook

Mexico Allergy Immunotherapy Market Outlook

Brazil Allergy Immunotherapy Market Outlook

MEA Allergy Immunotherapy Market Outlook

South Africa Allergy Immunotherapy Market Outlook

Saudi Arabia allergy immunotherapy market highlights

The Saudi Arabia allergy immunotherapy market generated a revenue of USD 1.6 million in 2019 and is expected to reach USD 2.4 million by 2027.
The Saudi Arabia market is expected to grow at a CAGR of 5.7% from 2020 to 2027.
In terms of segment, subcutaneous immunotherapy was the largest revenue generating treatment type in 2019.
Sublingual immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.

Allergy immunotherapy market data book summary

Market revenue in 2019	USD 1.6 million
Market revenue in 2027	USD 2.4 million
Growth rate	5.7% (CAGR from 2019 to 2027)
Largest segment	Subcutaneous immunotherapy
Fastest growing segment	Sublingual immunotherapy
Historical data	2016 - 2018
Base year	2019
Forecast period	2020 - 2027
Quantitative units	Revenue in USD million
Market segmentation	Subcutaneous immunotherapy, Sublingual immunotherapy
Key market players worldwide	Merck KGaA, Allergy Therapeutics PLC, DBV Technologies SA ADR, ASIT biotech, Circassia, Mylan, DMK Pharmaceuticals Corp, Alk-Abello A/S Class B, Desentum, HAL Allergy Group, HollisterStier Allergy, Stallergenes Greer

Other key industry trends

In terms of revenue, Saudi Arabia accounted for 0.1% of the global allergy immunotherapy market in 2019.
Country-wise, Germany is expected to lead the global market in terms of revenue in 2027.
In Middle East & Africa, South Africa allergy immunotherapy market is projected to lead the regional market in terms of revenue in 2027.
South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 7.3 million by 2027.

Key Regions: U.S. , Japan , Brazil , Canada , Germany

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Allergy Immunotherapy Market Scope

Allergy immunotherapy market segmentation & scope

Treatment Type

Subcutaneous immunotherapy

Sublingual immunotherapy

Tablets

Drops

Allergy Type

Allergic Rhinitis

Allergic Asthma

Other Allergies

Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Regions

Europe

Countries

U.S.

Canada

Germany

France

Japan

China

Brazil

Mexico

South Africa

Saudi Arabia

Allergy Immunotherapy Market Companies

Name	Profile	# Employees	HQ	Website

Saudi Arabia allergy immunotherapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to allergy immunotherapy market will help companies and investors design strategic landscapes.

Subcutaneous immunotherapy was the largest segment with a revenue share of 81.25% in 2019. Horizon Databook has segmented the Saudi Arabia allergy immunotherapy market based on subcutaneous immunotherapy, sublingual immunotherapy covering the revenue growth of each sub-segment from 2016 to 2027.

Saudi Arabia Allergy Immunotherapy Treatment Type Outlook (Revenue, USD Million, 2016-2027)
- Subcutaneous immunotherapy
- Sublingual immunotherapy
  - Tablets
  - Drops
Saudi Arabia Allergy Immunotherapy Allergy Type Outlook (Revenue, USD Million, 2016-2027)
- Allergic Rhinitis
- Allergic Asthma
- Other Allergies
Saudi Arabia Allergy Immunotherapy Distribution Channel Outlook (Revenue, USD Million, 2016-2027)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy

Reasons to subscribe to Saudi Arabia allergy immunotherapy market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia allergy immunotherapy market databook

Our clientele includes a mix of allergy immunotherapy market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia allergy immunotherapy market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia allergy immunotherapy market from 2016 to 2027, including revenue numbers, major trends, and company profiles.